Current state and future directions of neurochemical biomarkers for Alzheimer's disease

被引：66

作者：

de Jong, Dankille

Kremer, Berry P. H.

Olde Rikkert, Marcel G. M.

Verbeek, Marcel M.

机构：

[1] Radboud Univ Nijmegen Med Ctr, Dept Neurol, NL-6500 Nijmegen, Netherlands

[2] Radboud Univ Nijmegen Med Ctr, Alzheimer Ctr Nijmegen, Nijmegen, Netherlands

[3] Radboud Univ Nijmegen Med Ctr, Dept Geriatr Med, Nijmegen, Netherlands

[4] Radboud Univ Nijmegen Med Ctr, Lab Pediat & Neurol, Nijmegen, Netherlands

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2007年 / 45卷 / 11期

关键词：

Alzheimer's disease; amyloid beta protein; biological markers; cerebrospinal fluid; tau proteins;

D O I：

10.1515/CCLM.2007.320

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

In this comprehensive review, we summarize the current state-of-the-art of neurochemical biomarkers for Alzheimer's disease. Predominantly, these biomarkers comprise cerebrospinal fluid biomarkers directly related to the pathophysiology of this disorder (such as amyloid beta protein, tau protein). We particularly pay attention to the innovations in this area that have been made in technological aspects during the past 5 years (e.g., multiplex analysis of biomarkers, proteomics), to the discovery of novel, potential biomarkers (e.g., amyloid beta oligomers, isoprostanes), and to the extension of this research towards identification of biomarkers in plasma.

引用

收藏

页码：1421 / 1434

页数：14

相关论文

共 167 条

[1] Tau missing from CSF - A case report [J].

Alberici, Antonella ;

Armani, Mario ;

Paterlini, Anna ;

Benussi, Luisa ;

Nicosia, Francesca ;

Ghidoni, Roberta ;

Signorini, Simona ;

Cotelli, Maria ;

Frisoni, Giovanni B. ;

Geroldi, Cristina ;

Trevisan, Carlo P. ;

Growdon, John H. ;

Borroni, Barbara ;

Padovani, Alessandro ;

Rossini, Paolo M. ;

Binetti, Giuliano .

JOURNAL OF NEUROLOGY, 2007, 254 (01) :107-109

[2] Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment [J].

Andreasen, N ;

Minthon, L ;

Vanmechelen, E ;

Vanderstichele, H ;

Davidsson, P ;

Winblad, B ;

Blennow, K .

NEUROSCIENCE LETTERS, 1999, 273 (01) :5-8

[3] Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].

Andreasen, N ;

Vanmechelen, E ;

Van de Voorde, A ;

Davidsson, P ;

Hesse, C ;

Tarvonen, S ;

Räihä, I ;

Sourander, L ;

Winblad, B ;

Blennow, K .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305

[4] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].

Andreasen, N ;

Hesse, C ;

Davidsson, P ;

Minthon, L ;

Wallin, A ;

Winblad, B ;

Vanderstichele, H ;

Vanmechelen, E ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680

[5] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].

Andreasen, N ;

Minthon, L ;

Davidsson, P ;

Vanmechelen, E ;

Vanderstichele, H ;

Winblad, B ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379

[6] No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia [J].

Arai, H ;

Satoh-Nakagawa, T ;

Higuchi, M ;

Morikawa, Y ;

Miura, M ;

Kawakami, H ;

Seki, H ;

Takase, S ;

Sasaki, H .

NEUROSCIENCE LETTERS, 1998, 256 (03) :174-176

[7] TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].

ARAI, H ;

TERAJIMA, M ;

MIURA, L ;

HIGUCHI, S ;

MURAMATSU, T ;

MACHIDA, N ;

SEIKI, H ;

TAKASE, S ;

CLARK, CM ;

LEE, VMY ;

TROJANOWSKI, JQ ;

SASAKI, H .

ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652

[8] The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease [J].

Arnold, Steven E. ;

Hyman, Bradley T. ;

Flory, Jill ;

Damasio, Antonio R. ;

Van Hoesen, Gary W. .

CEREBRAL CORTEX, 1991, 1 (01) :103-116

[9] Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment [J].

Assini, A ;

Cammarata, S ;

Vitali, A ;

Colucci, M ;

Giliberto, L ;

Borghi, R ;

Inglese, ML ;

Volpe, S ;

Ratto, S ;

Dagna-Bricarelli, F ;

Baldo, C ;

Argusti, A ;

Odetti, P ;

Piccini, A ;

Tabaton, M .

NEUROLOGY, 2004, 63 (05) :828-831

[10] Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease [J].

Augustinack, JC ;

Schneider, A ;

Mandelkow, EM ;

Hyman, BT .

ACTA NEUROPATHOLOGICA, 2002, 103 (01) :26-35

← 1 2 3 4 5 6 7 8 9 10 →